
    
      If subjects are eligible and wish to enroll in the study, they will begin chemotherapy
      treatment with Gemcitabine and Abraxane. After subjects have received treatment with these
      drugs, they will have surgery. Subjects will also have post treatment and follow up
      evaluations. Subjects may have 2 cycles of treatment and each cycle is 28 days. All subjects
      will be followed every 3 months for 3 years after their initial registration.
    
  